Genzyme: Building a sustainable business model for orphan drugs in Asia

>Click here to download the presentation.

Gain knowledge on a sustainable business model on orphan drugs for rare diseases in Asia as Genzyme shares on the unique challenges and opportunities in the orphan drug market in Asia. Learn through case studies the importance of giving rare diseases more attention due to a lack of proper diagnosis, treatment and sustainable access. Genzyme further discusses the approach in overcoming limitations and looking forward, how to work towards supporting sustainable healthcare systems for innovation.

>Click here to download the presentation.

Attend World Orphan Drugs Congress Asia 2013 held on the 18-19 June 2013 at Grand Copthorne Waterfront Hotel, Singapore to learn more about orphan drugs. Register here to attend now!

Leave a Reply

Your email address will not be published. Required fields are marked *